Dare Bioscience
DARE
21 hedge funds and large institutions have $2.16M invested in Dare Bioscience in 2025 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 6 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 2
0% less capital invested
Capital invested by funds: $2.16M → $2.16M (-$4.07K)
2.73% less ownership
Funds ownership: 10.22% → 7.49% (-2.7%)
9% less funds holding
Funds holding: 23 → 21 (-2)
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$150K |
| 2 |
AE
AMH Equity
Great Neck,
New York
|
+$87.4K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$62.9K |
| 4 |
VF
Virtu Financial
New York
|
+$40K |
| 5 |
Raymond James Financial
St Petersburg,
Florida
|
+$30.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$105K |
| 2 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$40K |
| 3 |
Renaissance Technologies
New York
|
-$29.1K |
| 4 |
AF
Allworth Financial
Folsom,
California
|
-$3.98K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$3.44K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Morgan Stanley
New York
| – | -$17 | -7 | Closed |
|
|
PFG
27
Putney Financial Group
San Rafael,
California
| – | -$2 | -1 | Closed |
|
DARE Hedge Fund Activity: Q3 2025 in Review
21 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Dare Bioscience (DARE) for Q3 2025, worth a combined $2.16M — down 0.19% from $2.16M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of DARE and 4 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 8 added.
The largest buyer was Vanguard Group, adding an estimated $150K. The largest seller was Susquehanna International Group, cutting an estimated $105K.
- 21 institutional investors held Dare Bioscience (DARE) as of Q3 2025, down from 23 in Q2 2025.
- Funds reported $2.16M of Dare Bioscience stock for Q3 2025, down 0.19% quarter-over-quarter.
- 4 funds opened new Dare Bioscience positions in Q3 2025 and 6 closed out, a net change of -2 holders.
- The largest Dare Bioscience buyer in Q3 2025 was Vanguard Group, an estimated $150K added.
- The largest Dare Bioscience seller in Q3 2025 was Susquehanna International Group, an estimated $105K sold.
Based on aggregated 13F filings for Q3 2025.